Effectiveness of ranitidine bismuth citrate, clarithromycin, and metronidazole therapy for treating Helicobacter pylori

Citation
Dt. Smoot et al., Effectiveness of ranitidine bismuth citrate, clarithromycin, and metronidazole therapy for treating Helicobacter pylori, AM J GASTRO, 94(4), 1999, pp. 955-958
Citations number
16
Categorie Soggetti
Gastroenerology and Hepatology
Journal title
AMERICAN JOURNAL OF GASTROENTEROLOGY
ISSN journal
00029270 → ACNP
Volume
94
Issue
4
Year of publication
1999
Pages
955 - 958
Database
ISI
SICI code
0002-9270(199904)94:4<955:EORBCC>2.0.ZU;2-8
Abstract
OBJECTIVE: There are limited data available from the United States on the e ffectiveness of ranitidine bismuth citrate (RBC) plus two antibiotics to tr eat Helicobacter pylori. Therefore, the following study was undertaken to e valuate RBC with two antibiotics, which have been used successfully in comb ination, to treat H. pylori. METHODS: Adults with and without abdominal symptoms, who had never received H. pylori eradication therapy, were tested for the presence of H, pylori i nfection either by in-office rapid serology assays or histology. Positive s ubjects were administered the C-13-urea breath test. Subjects who had a pos itive urea breath test were then treated with RBC 400 mg b.i.d., clarithrom ycin 500 mg b.i.d., and met ronidazole 500 mg b.i.d. for 10 days. Four to 6 wk after completing antibiotics all subjects were asked to return for a se cond urea breath test to assess treatment success. RESULTS: Forty-seven of the 50 subjects enrolled into this study completed the antibiotic regimen and returned for a repeat urea breath test. Thirty-s even subjects were negative for H. pylori by urea breath test and 10 were p ositive, resulting in a 79% eradication rate. Seven subjects (14%) stopped their medication because of side effects. When analysis was performed on th e 40 subjects who took greater than or equal to 80% of their medication (pe r-protocol), the eradication rate was 90%. CONCLUSIONS: The combination of RBC with clarithromycin and metronidazole s uccessfully treated H. pylori infection after only 10 days of therapy. The per-protocol eradication rate from this study was similar to that seen with Food and Drug Administration (FDA)-approved regimens. In conclusion, RBC p lus clarithromycin and metronidazole should be considered as a first-line t reatment regimen for H. pylori infection, and may only need to be taken for a period of 10 days, as opposed to 14 days for FDA-approved regimens. (C) 1999 by Am. Cell. of Gastroenterology.